Hostname: page-component-6bf8c574d5-w79xw Total loading time: 0 Render date: 2025-02-15T11:26:45.892Z Has data issue: false hasContentIssue false
  • English
  • Français

Prescribing restrictions for expensive psychiatric drugs

Published online by Cambridge University Press:  02 January 2018

C. Bottomley  and
C. Hallstrom
C. Bottomley
Affiliation:
Chelsea and Westminster Hospital, London SW10 9NH
C. Hallstrom
Affiliation:
Charing Cross Hospital, London W6 8RF
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
Psychiatric Bulletin , Volume 19 , Issue 6 , June 1995 , pp. 377
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1995

References

Davies, L. M. & Drummond, M. F. (1990) The economic burden of schizophrenia. Psychiatric Bulletin, 14, 522–525.Google Scholar
Fitton, A. & Benfield, P. (1993) Clozapine: an appraisal of it's pharmacoeconomic benefits in the treatment of schizophrenia. Pharmacoeconomics, 4, 131–156.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.